Dr. Park is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4921 Parkview Pl
Saint Louis, MO 63110Phone+1 314-362-0000- Is this information wrong?
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Investigational Cancer Therapeutics Fellowship In Early Drug Development, 2014 - 2015
Virginia Commonwealth University Health SystemFellowship, Hematology and Medical Oncology, 2011 - 2014- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 2008 - 2011
Seoul National University College of MedicineClass of 2006
Certifications & Licensure
MA State Medical License 2022 - 2025
MO State Medical License 2015 - 2023
VA State Medical License 2008 - 2015- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Ramucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma Start of enrollment: 2017 Nov 01
- Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery Start of enrollment: 2018 Apr 20
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer Start of enrollment: 2019 Oct 10
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsChemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.Manji, G., Lee, S., Del Portillo, A., May, M., Ana, S., Alouani, E., Sender, N., Negri, T., Gautier, K., Ge, L., Fan, W., Xie, M., Sethi, A., Schrope, B., Tan, A., Par...> ;JAMA Oncology. 2023 Dec 1
- A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy.Patrick M Grierson, Rama Suresh, Benjamin Tan, Katrina S Pedersen, Manik Amin, Haeseong Park, Nikolaos A Trikalinos, Jingxia Liu, Nicholas Boice, Amberly Brown, Sapana...> ;Clinical Cancer Research. 2023 Dec 1
- 1 citationsImpact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial.Georg Pfeiler, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loib...> ;Journal of Clinical Oncology. 2023 Nov 20
- Join now to see all
Journal Articles
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersHaeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology
Authored Content
- FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020
Hospital Affiliations
Siteman Cancer CenterSaint Louis, Missouri
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
